Search clinical trials for: AOC 1044

Total 2223 results

Avidity Biosciences, Inc.

Enrolling by invitation

Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping (EXPLORE44OLE)

Duchenne Muscular Dystrophy | DMD | Exon 44 | Duchenne

United States
Avidity Biosciences, Inc.

Recruiting

Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping (EXPLORE44)

Duchenne Muscular Dystrophy | Exon 44

United States
Helios Albert-Schweitzer-Klinik Northeim

Completed

Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy (EC-Cap-SC)

Colorectal Polyps | Colorectal Adenomas

Germany, Poland
Barcelona Institute for Global Health

Not yet recruiting

A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

Infectious Disease | Child, Only | Febrile Illness
Molecular Insight Pharmaceuticals, Inc.

Completed

A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

Prostate Cancer

United States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
CymaBay Therapeutics, Inc.

Completed

Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Avidity Biosciences, Inc.

Completed

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients (MARINA)

Myotonic Dystrophy | Myotonic Disorders | Myotonic Dystrophy Type 1 (DM1) | Myotonic Dystrophy 1 | Myotonic Muscular Dystrophy | DM1 | Dystrophy Myotonic | Steinert Disease

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers (NRX-1074)

Major Depressive Disorder

United States
Curacle Co., Ltd.
KCRN Research, LLC

Completed

First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers

Diabetic Macular Edema

United States
Avidity Biosciences, Inc.

Recruiting

Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) (FORTITUDE)

Muscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditions

United States, United Kingdom, Canada
Avidity Biosciences, Inc.

Active, not recruiting

Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients (MARINA-OLE)

Nervous System Diseases | Genetic Diseases, Inborn | Musculoskeletal Diseases | Muscular Diseases | Neuromuscular Diseases | Neurodegenerative Diseases | Muscular Dystrophies | Muscular Disorders, Atrophic | Heredodegenerative Disorders, Nervous System | Myotonic Dystrophy | Myotonic Disorders | Myotonic Dystrophy... and other conditions

United States
Avidity Biosciences, Inc.

Not yet recruiting

Global Study of Del-desiran for the Treatment of DM1 (HARBOR)

Myotonic Dystrophy | Myotonic Disorders | Myotonia | Myotonic Dystrophy Type 1 (DM1) | Myotonic Dystrophy 1 | Myotonic Muscular Dystrophy | DM1 | Dystrophy Myotonic | Steinert Disease | Steinert
BioLineRx, Ltd.
Sheba Medical Center

Unknown

Safety and Feasibility of the Injectable BL-1040 Implant

Cardiovascular Disease

Germany
Elizabeth Glaser Pediatric AIDS Foundation
UNITAID

Completed

Impact of Point-of-Care EID for HIV-Exposed Infants (POC-EID)

HIV/AIDS | Infant Morbidity | Pediatric HIV Infection | Transmission, Perinatal Infection

Kenya, Zimbabwe
Universiteit Antwerpen
University Hospital, Antwerp; Kom Op Tegen Kanker

Completed

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET)

Neuroendocrine Tumors

Belgium
University Hospital, Antwerp
Universiteit Antwerpen

Recruiting

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Neuroendocrine Tumors

Belgium, Cyprus
NorthSea Therapeutics B.V.

Completed

A Phase 1, First Time in Humans Study of NST-1024

Hypertriglyceridemia

United Kingdom
Invicro

Completed

Assessment of [18F]MNI-1054 as a Marker for LSD1

Healthy Volunteers (HV)

United States
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Nocturia Due to Nocturnal Polyuria

Japan
Catabasis Pharmaceuticals

Completed

A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

Healthy

Netherlands
Suzhou Zanrong Pharma Limited

Recruiting

Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors

Advanced Solid Tumors | HER2-positive Breast Cancer

China
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Healthy

United States
Suzhou Zanrong Pharma Limited

Recruiting

A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors

Advanced Solid Tumors | HER2-positive Breast Cancer

United States
Catabasis Pharmaceuticals

Terminated

An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (GalaxyDMD)

Duchenne Muscular Dystrophy

United States, Canada, Australia, United Kingdom, Germany, Sweden
Invicro

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-1054

Healthy Volunteers

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer

Prostate Cancer

United States
Curacle Co., Ltd.
Théa Open Innovation, France

Completed

The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States, Puerto Rico
Molecular Insight Pharmaceuticals, Inc.

Completed

Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer (proSPECT-AS)

Prostate Cancer

United States, Canada
Euclises Pharmaceuticals, Inc.

Recruiting

ECP-1014 Treatment for Patients With Solid Tumor Cancers

Solid Tumor

China
Steno Diabetes Center Copenhagen
University of Copenhagen

Completed

The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes

Glucose Metabolism Disorders | Type1diabetes | Type1 Diabetes Mellitus

Denmark
Mahidol University

Recruiting

The Safety and Efficacy of 1064-nm Picosecond Laser With Microlens Array for Pore Tightening; a Pilot Study

Enlarged Pores

Thailand
Catabasis Pharmaceuticals

Completed

Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy (MoveDMD®)

Muscular Dystrophy, Duchenne

United States
Aalborg University Hospital

Completed

Laser Treatment of Toenail Onychomycosis With a 1064 nm Nd:YAG-laser

Onychomycosis of Toenail

Denmark
Catabasis Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers

Healthy

United States
Boehringer Ingelheim

Completed

Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers

Healthy
University of Sao Paulo

Completed

Laser Treatment Of Leg Telangiectasias

Leg Veins

Brazil
Merck Sharp & Dohme LLC

Completed

A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064 (MK-1064-001)

Pharmacokinetics
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study

Nocturia

United Kingdom
Molecular Insight Pharmaceuticals, Inc.

Completed

Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404

Prostate Cancer

United States
Institute of Medicinal Molecular Design, Inc.

Unknown

IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
BioMarin Pharmaceutical

Terminated

Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

Netherlands, Belgium, Italy, Sweden
International AIDS Vaccine Initiative
Brigham and Women's Hospital; Fred Hutchinson Cancer Center; Rockefeller University

Active, not recruiting

Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults

HIV-1-infection

United States, Uganda, Kenya, Rwanda, South Africa
Aviceda Therapeutics, Inc.

Terminated

A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

United States
IconOVir Bio

Recruiting

Safety and Tolerability of Intravenous Administration of ICVB-1042

Patients With Advanced Solid Tumors

United States
Christopher Zachary

Recruiting

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma

Basal Cell Carcinoma | Nodular Basal Cell Carcinoma | Superficial Basal Cell Carcinoma

United States
Sciton

Completed

Laser Treatment of Basal Cell Carcinoma

Basal Cell Carcinoma

United States
Dominion Aesthetic Technologies, Inc.

Completed

Eon™ FR Clinical Study Protocol 1064

Fat Disorder

United States

Search clinical trials for: AOC 1044

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations